Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
Authors
Keywords
-
Journal
CIRCULATION
Volume 144, Issue 3, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-06-17
DOI
10.1161/cir.0000000000000986
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
- (2020) José López-Sendón et al. EUROPEAN HEART JOURNAL
- Risk of QTc Prolongation Among Cancer Patients Treated with Tyrosine Kinase Inhibitors
- (2020) Anan A. Abu Rmilah et al. INTERNATIONAL JOURNAL OF CANCER
- MEXILETINE: A TREATMENT FOR ALL CAUSE ACQUIRED QT INTERVAL PROLONGATION
- (2020) Muhammad Shakir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- (2020) Joerg Herrmann Nature Reviews Cardiology
- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
- (2020) Paulus Kirchhof et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis
- (2019) Daniel Caldeira et al. PLoS One
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared to Cytotoxic Chemotherapy
- (2019) Michael G. Fradley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma
- (2019) C. Owen et al. Current Oncology
- QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics
- (2019) Sanjay Chandrasekhar et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium
- (2019) Le Jiang et al. HEART RHYTHM
- Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
- (2019) Susan C. Gilchrist et al. CIRCULATION
- Arrhythmogenic Anticancer Drugs in Cardio-Oncology
- (2019) Isaac Rhea et al. CARDIOLOGY CLINICS
- Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy
- (2019) Jagmeet P. Singh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular Toxicities Associated With Ibrutinib
- (2019) Joe-Elie Salem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond
- (2019) Mohammed Alomar et al. Journal of Cardiovascular Translational Research
- Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
- (2019) Raza M. Alvi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stroke Prevention in Nonvalvular Atrial Fibrillation
- (2018) Mohamad Alkhouli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer
- (2018) Maria D’Souza et al. European Journal of Preventive Cardiology
- Cardiovascular Autonomic Dysfunction in Patients with Cancer
- (2018) Ben G. T. Coumbe et al. Current Cardiology Reports
- Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies
- (2018) Avirup Guha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Longitudinal Study of the Association of Clinical Indices of Cardiovascular Autonomic Function with Breast Cancer Treatment and Exercise Training
- (2018) Amy A. Kirkham et al. ONCOLOGIST
- Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients
- (2018) Mariana L. Henry et al. JACC-Cardiovascular Imaging
- Atrial Fibrillation and Risk of Cancer: A Danish Population‐Based Cohort Study
- (2018) Nicklas Vinter et al. Journal of the American Heart Association
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- (2017) Andreu Porta‐Sánchez et al. Journal of the American Heart Association
- Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment
- (2017) Nejka Potočnik et al. PLoS One
- Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study
- (2016) G Deuring et al. BONE MARROW TRANSPLANTATION
- Drug Interactions of Direct-Acting Oral Anticoagulants
- (2016) John Leonard Fitzgerald et al. DRUG SAFETY
- High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate
- (2016) Rehana Jamani et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
- (2016) Jeffrey H Lipton et al. LANCET ONCOLOGY
- Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes
- (2016) Fangyi Sun et al. MEDICINE
- Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large-scale multinational trials (PROFILE 1005 and 1007)
- (2016) Sai-Hong Ignatius Ou et al. Cancer Medicine
- Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms
- (2015) Susan G. Lakoski et al. AMERICAN HEART JOURNAL
- Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)
- (2015) Wesley T. O'Neal et al. AMERICAN JOURNAL OF CARDIOLOGY
- Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions
- (2015) R. W. F. van Leeuwen et al. ANNALS OF ONCOLOGY
- Arrhythmias in the setting of hematopoietic cell transplants
- (2015) E S Tonorezos et al. BONE MARROW TRANSPLANTATION
- Abnormal Exercise Response in Long-Term Survivors of Hodgkin Lymphoma Treated With Thoracic Irradiation
- (2015) John D. Groarke et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Orthostatic Hypotension
- (2015) Fabrizio Ricci et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evidence of altered autonomic cardiac regulation in breast cancer survivors
- (2015) Chiara Vigo et al. Journal of Cancer Survivorship
- Role of Sarcoplasmic Reticulum Calcium in Development of Secondary Calcium Rise and Early Afterdepolarizations in Long QT Syndrome Rabbit Model
- (2015) Po-Cheng Chang et al. PLoS One
- Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling
- (2014) J. R. McMullen et al. BLOOD
- Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
- (2013) Anne Polk et al. CANCER TREATMENT REVIEWS
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
- (2013) EUROPEAN HEART JOURNAL
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antineoplastic drug-induced bradyarrhythmias
- (2012) Carla Minoia et al. Expert Opinion On Drug Safety
- Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
- (2011) Iacopo Petrini et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Melphalan-Induced Supraventricular Tachycardia: Incidence and Risk Factors
- (2011) Victor Feliz et al. CLINICAL CARDIOLOGY
- Cancer Induces Cardiomyocyte Remodeling and Hypoinnervation in the Left Ventricle of the Mouse Heart
- (2011) Christian Mühlfeld et al. PLoS One
- Usefulness of Cardiac Resynchronization Therapy in Patients With Adriamycin -Induced Cardiomyopathy
- (2010) John Rickard et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevention of Torsade de Pointes in Hospital Settings
- (2010) Barbara J. Drew et al. CIRCULATION
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
- (2009) Pentti M. Rautaharju et al. CIRCULATION
- Usefulness of Cardiac Resynchronization Therapy in the Management of Doxorubicin-Induced Cardiomyopathy
- (2008) Olujimi A. Ajijola et al. AMERICAN JOURNAL OF CARDIOLOGY
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
- (2008) et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search